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Isolation and structural determination of non-racemic 
tertiary cathinone derivatives	  	  
M.-­‐J.	  Zhou,a	  S.	  Bouazzaoui,a	  L.	  E.	  Jones,a	  P.	  Goodrich,a	  S.	  J.	  E.	  Bell,a	  G.	  N.	  Sheldrake,a	  P.	  N.	  Horton,	  b	  
S.	  J.	  Coles,b	  and	  N.	  C.	  Fletcher*a,c	  	  
The	  racemic	  tertiary	  cathinones	  N,N-­‐dimethylcathinone	  (1),	  N,N-­‐diethylcathinone	  (2)	  and	  2-­‐(1-­‐pyrrolidinyl)-­‐propiophenone	  
(3)	   have	   been	   prepared	   in	   reasonable	   yield	   and	   characterized	   using	   NMR	   and	  mass	   spectroscopy.	   HPLC	   indicates	   that	  
these	   compounds	   are	   isolated	   as	   the	   anticipated	   racemic	  mixture.	   These	   can	   then	  be	   co-­‐crystallized	  with	   (+)-­‐O,Oʹ′-­‐di-­‐p-­‐
toluoyl-­‐D-­‐tartaric,	  (+)-­‐O,Oʹ′-­‐dibenzoyl-­‐D-­‐tartaric	  and	  (−)-­‐O,Oʹ′-­‐dibenzoyl-­‐L-­‐tartaric	  acids	  giving	  the	  single	  enantiomers	  S	  and	  
R	   respectively	  of	  1,	  2	  and	  3,	   in	   the	  presence	  of	  sodium	  hydroxide	  through	  a	  dynamic	  kinetic	   resolution.	  X-­‐ray	  structural	  
determination	  confirmed	  the	  enantioselectivity.	  The	  free	  amines	  could	  be	  obtained	  following	  basification	  and	  extraction.	  
In	  methanol	  these	  are	  reasonably	  stable	  for	  the	  period	  of	  several	  hours,	  and	  their	  identity	  was	  confirmed	  by	  HPLC	  and	  CD	  
spectroscopy.	  
Introduction	  
Because	  of	  both	  market	   trends	  and	   legislative	   controls,	   there	  
has	   been	   an	   increasing	   number	   of	   recreational	   'designer'	  
entactogenic	  drugs	  available	  on	  the	  market,	  often	  miss	  sold	  as	  
“legal	   highs”.1,2	   In	   particular,	   β-­‐ketone	   derivatives	   of	  
amphetamine,	   commonly	   known	   as	   “cathinones”,	   have	   been	  
found	   in	   many	   samples	   analysed	   forensically	   (Figure	   1).3,4	  
Cathinone	  itself	  is	  a	  stimulative	  alkaloid	  found	  in	  Catha	  edulis,	  
or	   Khat,	   widely	   cultivated	   in	   Eastern	   Africa	   and	   the	   Arabian	  
Peninsula,5	   but	   the	   synthetic	   N-­‐methylated	   derivatives	  
methcathinone	  and	  4-­‐methylmethcathinone	  or	  “mephedrone”	  
have	  been	  shown	  to	  be	  considerably	  more	  potent.6,7	  The	  latter	  
has	  become	  a	  major	   international	   concern,8	  being	   the	   first	  of	  
many	  derivatized	   cathinones	   to	  be	   identified	   in	  drug	   seizures	  
and	   commercially	   available	   products	   sold	   under	   a	   variety	   of	  
guises	   such	   as	   “plant	   food”	   or	   “bath	   salts”.9-­‐11	   Yet	   an	  
understanding	   of	   both	   the	   long,	   and	   short-­‐term	  
pharmacological	   effects	   of	   many	   of	   these	   recently	   identified	  
materials	   is	   limited	   which	   is,	   in	   part,	   due	   to	   the	   difficulty	   in	  
obtaining	  pure	  characterized	  materials	  from	  reliable	  sources.	  
	   The	   forensic	   identification	  of	   the	  ever-­‐expanding	   range	  of	  
cathinone	   derivatives	   has	   relied	   upon	   GC	   /	   MS	   detection	  
against	   known	   standards,	   however	   the	   rapid	   proliferation	   of	  
these	  new	  materials	  means	  that	  routine	  identification	  is	  now	  a	  
considerable	   challenge.12-­‐15	   Several	   new	   techniques	   are	   now	  
being	  applied	  to	  both	  rapidly	  screen	  seized	  samples,16-­‐19	  and	  to	  
identify	   metabolized	   products.20-­‐23	   These	   include	  
electrochemistry24	   and	   the	   use	   of	   SERS	   Raman	   spectroscopy	  
studied	  by	  both	  Mabbott	  et	  al.25,26	  and	  ourselves,27	  in	  addition	  
to	   the	   traditional	   chromatographic	   mass	   spectrometric	  
techniques.	  The	  availability	  of	   legitimate	  synthetic	  procedures	  
has,	  until	   relatively	   recently,	   also	   lagged	  behind	   the	  presence	  
of	   these	   new	   substances	   in	   the	  market	   place.6,7	   Studies	   have	  
now	  shown	  that	  a	  wide	  range	  of	  cathinone	  derivatives	  can	  be	  
reliably	  obtained	  using	  a	  synthetic	  pathway	  initially	  reported	  in	  
195028	   via	   the	   acid-­‐catalyzed	   bromination	   of	   the	   appropriate	  
aryl	   ketone,	   followed	   by	   amination	   to	   give	   the	   target	   as	   a	  
racemic	  product.29-­‐37	  
	   The	  majority	  of	  the	  seized	  derivatized	  cathinone	  materials	  
are	   assumed	   to	   be	   racemic,	   although	   there	   has	   not	   been	   a	  
systematic	   study	   to	   demonstrate	   this.	   They	   are	   normally	  
obtained	  in	  a	  stable	  protonated	  solid	  form,	  generally	  assumed	  
to	   be	   the	   chloride	   salt.	   As	   the	   free	   amine,	   cathinone	  
derivatives	   are	   unstable	   to	   decomposition,	   and	   undergo	  
racemization	  due	  to	  keto-­‐enol	  tautomerism.3	  Calculations	  have	  
predicted	   the	  pKa	   to	  be	   in	   the	   range	  of	  8.4	   to	  9.5,	   suggesting	  
that	  these	  compounds	  remain	  protonated	  at	  physiological	  pH,	  
and	   unlike	   the	   analogous	   amphetamine	   derivatives,	   it	   is	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predicted	   that	   the	   ketone	   group	   increases	   both	   the	   planarity	  
of	   the	   compound,	   and	   the	   hydrophilicity	   so	   lowering	   their	  
activity	   with	   respect	   to	   the	   parent	   amphetamine,	   being	   less	  
likely	   to	   cross	   cell	   membranes.38	   Despite	   these	   limitations,	  
studies	  have	  shown	  that	  as	  with	  amphetamine,	  S-­‐(-­‐)-­‐cathinone	  
and	  S-­‐(-­‐)-­‐methcathinone	  have	  a	  greater	  pharmacological	  effect	  
in	   rats	   over	   the	   R-­‐forms,6,39	   although	   the	   pharmacological	  
effects	  appear	  to	  be	  species	  dependent.40	  
	   To	   gain	   a	   good	   understanding	   of	   the	   pharmacological	  
effects	   of	   these	   cathinone	   derivatives,	   and	   to	   possibly	   gain	   a	  
forensic	   advantage	   on	   seized	   materials,	   a	   range	   of	  
chromatographic	   techniques	   have	   been	   considered	   for	   their	  
enantiomeric	  separation.	  These	  include	  using	  HPLC	  with	  either	  
a	  chiral	  stationary	  phase41-­‐44	  or	  a	  chiral	  additive	  to	  the	  eluent,45	  
GC	   following	   chiral	   derivatization	   of	   the	   analyte,30,42,46-­‐48	  
capillary	   electrophoresis,49-­‐52	   and	   NMR	   spectroscopy	   using	  
appropriate	   chiral	   auxiliaries.30,53	   However,	   many	   cathinone	  
derivatives,	  particularly	  those	  with	   larger	  groups	  appended	  to	  
the	   nitrogen	   do	   not	   readily	   provide	   clear	   baseline	  
chromatographic	  separation,	  and	  can	  decompose	  /	  racemize	  in	  
the	  process.	  Consequently	  these	  techniques	  are	  unsuitable	  to	  
provide	   enantiopure	   materials	   in	   reasonable	   quantity.	   S-­‐(-­‐)-­‐
N,N-­‐dimethylcathinone,37,42,54	   S-­‐(-­‐)-­‐N-­‐methylcathinone6,29,30,42	  
and	   S-­‐(-­‐)-­‐cathinone55	   have	   however	   been	   isolated	   from	   the	  
natural	   products	   R/S-­‐N-­‐methylephedrine,	   R/S-­‐ephedrine	   and	  
R/S-­‐norephedrine	   respectively	   by	   either	   permanganate	   or	  
chromate	   oxidation.	   This	   route	   does	   limit	   the	   isolation	   of	  
enantiopure	  materials	  to	  the	  availability	  of	  naturally	  occurring	  
precursors,	   and	   potentially	   results	   in	   products	   contaminated	  
with	   carcinogenic	   metal	   ions.	   Osorio-­‐Olivares	   et	   al.	   also	  
demonstrated	   that	   non-­‐racemic	   cathinone	   derivatives	   can	   be	  
isolated	  with	   high	   enantiopurity	   via	   a	   Friedel-­‐Crafts	   acylation	  
of	   substituted	   aromatic	   systems	   with	   S-­‐	   or	   R-­‐N-­‐trifluoro-­‐
acetylalanyl	   chloride.56	  Whilst	   the	   chloride	   salt	   of	   these	   non-­‐
racemic	  materials	  appear	  to	  be	  stable	  over	  several	  months,	   it	  
is	  reported	  that	  racemization	   is	  possible	  during	  basification	   in	  
the	  final	  isolation	  of	  a	  free	  amine.52	  
	   To	   investigate	   the	   possibilities	   to	   obtain	   non-­‐racemic	  
cathinone	  derivatives	  preparatively,	  we	  report	  here	  a	  method	  
to	   separate	   three	   cathinone	   derivatives	   with	   tertiary	   amines	  
groups	   by	   co-­‐crystallization	   of	   the	   protonated	   forms	   from	  
aqueous	   solution.	   The	   tertiary	   amines,	   unlike	   the	  
amphetamine	   analogues	   appear	   to	   have	   a	   significant	  
pharmacological	   effect,37,54	   pressumably	   because	   of	   the	  
greater	   lipophilicity.	   In	  particular,	   the	  pyrrolidine	  function	  has	  
been	  identified	  in	  a	  number	  of	  materials	  being	  regularly	  found	  
in	  forensic	  analysis	  such	  as	  4-­‐methylpyrrolidinopropiophenone	  
(MPPP),	   pyrovalerone	   and	   3,4-­‐methylenedioxypyrovalerone	  
(MDPV).9-­‐11	  Importantly	  to	  this	  study,	  they	  appear	  to	  be	  more	  
stable	   to	   decomposition	   in	   comparison	   to	   the	   primary	   and	  
secondary	   amines	   permitting	   determination	   of	   their	  
enantiopurity	  with	  relative	  ease.	  
Results	  and	  discussion	  
The	   targeted	   tertiary	  amines	  N,N-­‐dimethylcathinone	   (1),	  N,N-­‐
diethylcathinone	   (2)	   and	   2-­‐(1-­‐pyrrolidinyl)-­‐propiophenone	   (3)	  
were	   prepared	   via	   2-­‐bromopropiophenone	   using	   an	   adapted	  
procedure	   previously	   reported	   for	   the	   preparation	   of	   (±)-­‐4’-­‐
methyl-­‐2-­‐bromopropiophenone,31	  giving	  characterization	  data	  
consistent	   with	   that	   recently	   reported	   by	   Smith	   et	   al.24	   This	  
compound	  is	  a	  severe	  lachrymator	  and	  should	  be	  handled	  with	  
extreme	  care.	  This	  was	   then	   readily	  converted	   to	  compounds	  
1,	   2	   and	   3	   by	   the	   addition	   of	   just	   under	   a	   stoichiometric	  
amount	   of	   either	   dimethylamine	   hydrochloride	   or	  
diethylamine	   hydrochloride	   in	   an	   excess	   of	   triethlyamine,	   or	  
pyrrolidine	   respectively	   in	   reasonable	   yields	   (60	   to	   85%).37,54	  
The	  identity	  of	  compounds	  1,	  2	  and	  3	  were	  confirmed	  by	  both	  
1H	  NMR	  and	   13C	  NMR	  spectroscopy	   (Figure	   S1-­‐3),	   as	  well	   has	  
high	  resolution	  TOF	  EI	  mass	  spectrometry.	  In	  comparison	  to	  N-­‐
methylcathinone	   and	   mephedrone	   previously	   prepared	   by	  
ourselves,27	  the	  free	  amines	  of	  1,	  2	  and	  3	  were	  observed	  to	  be	  
	  
Scheme	  1:	  The	  route	  to	  enantio-­‐separation	  of	  cathinones	  1,	  2	  and	  3.	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considerably	   more	   stable	   to	   decomposition,	   however	   they	  
were	  stored	  under	  nitrogen	  and	  at	  -­‐30	  °C	  prior	  to	  use.	  
	   The	  addition	  of	  a	  non-­‐racemic	  chiral	  acid	  should	  permit	  the	  
selective	  co-­‐crystallization,	  with	  the	  preferential	  formation	  of	  a	  
single	   diastereoisomer.	   Enantiopure	   (+)-­‐O,O’-­‐di-­‐p-­‐toluoyl-­‐D-­‐
tartaric	   acid	   (D-­‐DTT)	   was	   initially	   investigated,	   in	   a	   range	   of	  
stoichiometries,	   with	   the	   best	   results	   found	   using	   one	  
equivalent	  of	  the	  di-­‐acid	  relative	  to	  the	  cathinones	  derivative,	  
alongside	  one	  equivalent	  of	  sodium	  hydroxide	  on	  the	  rationale	  
that	   the	   orientation	   of	   the	   two	   aromatic	   functions	   could	  
enhance	   the	   diastereomeric	   differences	   through	   π-­‐stacking	  
interactions	   from	   the	   aqueous	   solution,	   consistent	   with	   the	  
ideas	   previously	   reported	   by	   Berrang	   et	   al.	   with	   (±)-­‐
norephedrine.55	   This	   proved	   to	   be	   correct,	   with	   good	   quality	  
crystals	   forming	   over	   the	   period	   of	   several	   days.	   Attempts	  
were	  made	  to	  optimize	  the	  conditions	  using	  a	  small	  amount	  of	  
sodium	   hydroxide	   solution	   to	   encourage	   solubility	   of	   the	  
selected	   chiral	   anions	   (Scheme	   1).	   No	   success	   was	   observed	  
however	  with	  organic	  acids	  such	  as	  L-­‐tartaric	  acid,	  or	  (1S)-­‐(+)-­‐
10-­‐camphorsulfonic	   acid	   in	   keeping	   with	   earlier	   studies	  
observed	  with	  cathinone	  itself.55	  	  
	   With	   D-­‐DTT	   in	   the	   presence	   of	   sodium	   hydroxide	   and	  
compound	   1,	   needle	   like	   crystals	   (1-­‐D-­‐DTT)	   readily	   formed	  
following	   the	   evaporation	   of	   the	   acetone	   in	   a	   yield	   of	   up	   to	  
68%.	  The	  yield	   itself	  was	   initially	  surprising	  assuming	  that	   the	  
observed	   process	   is	   a	   diastereoselective	   crystallization	  
process.	   However	   given	   the	   possibility	   of	   a	   degree	   of	  
racemization	   occurring	   in	   the	   basic	   solution	   presumably	   by	  
keto-­‐enol	   tautomerism,3	   the	   selective	   removal	   of	   one	  
enantiomer	  allows	  re-­‐equilibration	  providing	  opportunities	  for	  
a	  dynamic	  resolution,	  and	  a	  yield	  of	  up	  to	  78%	  was	  recorded	  in	  
the	  case	  of	  2-­‐D-­‐DTT.	   	  However,	   lower	  yields,	  typically	  22%	  (3-­‐
D-­‐DTT)	   were	   obtained	   in	   many	   cases,	   especially	   with	  
compound	   3,	   as	   the	   product	   was	   isolated	   before	   complete	  
precipitation	   had	   occurred.	   It	   was	   observed	   that	   if	   a	   longer	  
period	  of	   time	  was	   required	   for	   the	  crystallization	  procedure,	  
the	   product	   darkened	   in	   colour,	   resulting	   in	   poorer	   quality	  
crystals	   /	   precipitates,	   presumably	   caused	   by	   partial	  
decomposition	  of	   the	  parent	  cathinone.	  The	  1H	  NMR	  solution	  
spectra	   of	   the	   co-­‐crystallized	   products	   indicated	   that	   in	   each	  
case	  a	  one	  to	  one	  stoichiometry	  of	  one	  cathinone	  is	  associated	  
with	   one	   D-­‐DTT	   (DMSO-­‐D6;	   Figures	   S4-­‐S12).	   Similarly,	   the	  
electrospray	   mass	   spectrometry	   confirmed	   the	   association	  
through	   the	   detection	   of	   the	   ion	   pairs	   at	   564.2187	   and	  
590.1918	   for	  1-­‐D-­‐DTT	  and	  3-­‐D-­‐DTT	   respectively,	   although	   the	  
dominant	   species	   in	   each	   case	   was	   unsurprisingly	   the	  
protonated	  cathinone	  itself.	  
	   Following	   the	   initial	   success	   with	   D-­‐DTT,	   both	   (+)-­‐O,Oʹ′-­‐
dibenzoyl-­‐D-­‐tartaric	  and	   (−)-­‐O,Oʹ′-­‐dibenzoyl-­‐L-­‐tartaric	  acids	   (D-­‐	  
and	   L-­‐DBT)	   were	   also	   considered	   under	   the	   same	   conditions	  
resulting	   in	   colourless	   crystals	   with	   compound	   1	   giving	   1-­‐D-­‐
DBT	  and	  1-­‐L-­‐DBT	  respectively.	  Compounds	  2	  and	  3	  again	  took	  
longer	   to	   crystallize	   typically	   giving	   coloured	   precipitates	  
rather	   than	   distinct	   crystals	   suggesting	   that	   a	   larger	  
functionality	  on	  the	  nitrogen	  atom	  frustrates	  the	  crystallization	  
process.	  Similarly,	  the	  quality	  of	  the	  material	  obtained	  using	  L-­‐
DBT	  was	   significantly	   lower	   than	   those	   obtained	   using	   either	  
the	  D	   form	  or	  with	  D-­‐DTT,	  which	  was	   assumed	   to	   arise	   from	  
the	   marginally	   lower	   enantiopurity	   (97%)	   of	   the	   starting	  
material	   used.	   For	   each	   of	   the	   salts	   obtained,	   a	   one	   to	   one	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stoichiometry	   was	   again	   confirmed	   by	   both	   1H	   NMR	  
spectroscopy	  and	  the	  electrospray	  mass	  spectrometry.	  	  
	   The	   X-­‐ray	   structural	   determination	   of	   1-­‐D-­‐DTT	   similarly	  
confirmed	   the	   solution	   based	   stoichiometry	   and	   proved	   that	  
the	   crystallisation	  process	   resulted	   in	  a	  diastereoselectivity	   in	  
the	  product,	  with	  di-­‐p-­‐toluoyl-­‐D-­‐tartaric	  acid	  crystallizing	  solely	  
as	   the	  S-­‐isomer	   (Figure	   3).	   The	   stereochemistry	  was	   assigned	  
relative	  to	  the	  starting	  tartaric	  acid	  and	  whilst	  only	  one	  crystal	  
was	   evaluated,	   the	  morphology	  was	   consistent	  with	   the	   bulk	  
sample.	   The	   close	   contact	   between	   the	   cathinone	   amine	   and	  
one	   of	   the	   two	   tartaric	   carboxylic	   acid	   groups	   is	   2.708	   Å,	  
suggesting	  a	  hydrogen	  bond,	  and	  possible	  displacement	  of	  the	  
acid	  proton	  to	  the	  nitrogen	  in	  the	  solid-­‐state.	  Interestingly	  for	  
the	  cathinone	  itself	  the	  aromatic	  ring,	  and	  the	  ketone	  are	  close	  
to	   being	   planar,	   with	   a	   torsion	   angle	   of	   19.38°,	   bringing	   the	  
ketone	  and	  amine	  in	  close	  contact	  (2.521	  Å).	  These	  findings	  are	  
in	   keeping	  with	   the	   calculations	   reported	   by	   Gibbons	   et	   al.38	  
and	   the	   previously	   reported	   hydrogen	   chloride	   salt	   of	   both	  
mephedrone	   and	   pentedrone.57	   The	   tartaric	   acid	   itself	   has	   a	  
trans	   configuration	   enabling	   a	   chain	   like	   hydrogen	   bonded	  
conformation	  with	  itself	  (2.469	  Å)	  along	  the	  b	  crystallographic	  
axis	   and	   a	   secondary	   N-­‐H-­‐O	   hydrogen	   bond	  with	   the	   ketone	  
(Figure	  4).	  
	   Converting	   the	   crystalline	   salts	   back	   to	   the	   free	   amines	  
allowed	   analysis	   of	   the	   enantioselectivity	   of	   the	   co-­‐
precipitation	   with	   the	   aromatic	   tartaric	   acids.	   This	   was	  
achieved	   by	   dissolving	   a	   small	   quantity	   of	   the	   crystals	   up	   in	  
dilute	  aqueous	  sodium	  hydroxide	  solution	  and	  extraction	   into	  
dichloromethane	   followed	   by	   evaporation.	   Given	   that	   the	  
compounds	  were	  observed	   to	   racemize	   in	  basic	   solution,	   this	  
procedure	  was	  completed	  as	  quickly	  as	  possible,	  and	  samples	  
were	   only	   prepared	   directly	   before	   subsequent	   use.	   In	   each	  
case,	   an	   oil	   of	   similar	   appearance	   to	   the	   racemate	   was	  
obtained,	  each	  giving	  identical	  1H	  NMR	  and	  ES	  mass	  spectra	  to	  
the	   starting	   compounds	  1,	  2	   and	  3	   respectively	   (Figures	   S13-­‐
16),	   and	   given	   the	   necessity	   to	   work	   quickly,	   the	   extraction	  
process	   was	   not	   optimized.	   If	   the	   procedure	   was	   completed	  
using	  either	  aqueous	  sodium	  bicarbonate,	  or	   triethylamine	  as	  
the	  base,	  lower	  yields	  were	  typically	  obtained.	  
	   The	   chiral	   stationary	   phase	   HPLC	   studies	   on	   both	   the	  
racemic	   cathinones	   1,	   2	   and	   3	   along	   side	   the	   materials	  
retrieved	  following	  co-­‐crystallization	  with	  the	  aromatic	  tartrate	  
salts	  were	  attempted	  with	   the	  best	   separation	  observed	  with	  
n-­‐hexane	   and	   2-­‐propanol	   (98:2)	   on	   an	   OJ-­‐H	   column.	   For	  
compound	   1,	   while	   two	   peaks	   are	   observed,	   clear	   baseline	  
separation	  could	  not	  be	  obtained	  (Figure	  5a).	  For	  the	  resolved	  
enantiomers	  of	  1,	  formed	  from	  the	  extraction	  of	  the	  D-­‐DTT,	  D-­‐
DBT	   and	   L-­‐DBT	   salts,	   only	   a	   single	   peak	   is	   observed	   under	  
similar	  conditions	  by	  HPLC,	  albeit	  being	  relatively	  broad	  (Figure	  
S17).	  Given	   that	   the	  absolute	   stereochemistry	  determined	  by	  
crystallography	  within	  1-­‐D-­‐DTT,	   is	   the	  S-­‐form	   (S-­‐1),	   it	   appears	  
that	  this	  elutes	  before	  R-­‐1.	  A	  very	  similar	  result	  obtained	  from	  
1-­‐D-­‐DBT	  suggests	  that	  the	  use	  of	  D-­‐DTT	  and	  D-­‐DBT	  result	  in	  the	  
same	  selectivity	  and	  is	  assumed	  to	  be	  S-­‐1	  although	  due	  to	  the	  
experimental	   constraints	   to	   determine	   the	   samples	   directly	  
after	   preparation	   to	   avoid	   racemization	   and	   decomposition,	  
and	  the	  fact	  that	  samples	  could	  not	  be	  run	  sequentially,	  there	  
is	  unfortunately	  a	  degree	  of	  variation	  in	  the	  data	  obtained.	  	  
	   For	   racemic	   compound	   2,	   two	   well-­‐resolved	   peaks	   were	  
again	   not	   observed,	   although	   a	   variety	   of	   different	  
temperatures	  and	  eluent	  ratios	  (2-­‐propanol	  in	  n-­‐hexane)	  were	  
explored.	  However,	  the	  principle	  peak	  had	  a	  notable	  shoulder	  
consistent	  with	   the	   presence	   of	   the	   two	   enantiomers	   (Figure	  
5b).	  The	  traces	  for	  the	  products	  obtained	  from	  the	  crystalline	  
tartrate	   salts	   gave	   narrower	   peaks	   with	   the	   two	   potentially	  
separated	   enantiomers	   having	   marginally	   different	   retention	  
	  
Table	  1	  HPLC	  Enantioseparation	  on	  compounds	  1,	  2	  and	  3.	  
Compound	   t1	  (min)	   t2	  (min)	  
1	   7.47	   7.88	  
2	   7.43	   7.74	  
3	   11.45	   11.89	  
Conditions:	  CHIRACEL®	  OJ-­‐H	  HPLC	  column	  (250	  x	  10	  mm,	  5	  μm),	  2%	  2-­‐
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times	   (Figure	   S18).	   Possible	   variation	   in	   the	   data	   given	   the	  
experimental	   requirements	   is	   acknowledged	   however.	  
Similarly	   for	  compound	  3,	   the	  result	  was	  not	   ideal	   (Figure	  5c)	  
possessing	  a	  long	  tail	  assigned	  as	  compound	  decomposition	  on	  
the	   column.	   Again	  with	   no	   clear	   baseline	   separation,	   but	   the	  
compounds	   isolate	   from	   3-­‐D-­‐DBT	   ad	   3-­‐L-­‐DBT	   eluted	   with	  
different	   retention	   times	   as	   single	   broad	   peaks	   indicating	  
success	  in	  the	  chiral	  separation	  (Figure	  S19).	  
	   Analysis	   of	   the	   optical	   rotation	   of	   each	   of	   the	   samples	  
obtained	   from	   extraction	   from	   the	   co-­‐crystallized	   products	  
proved	  problematic,	  which	  is	  unsurprising	  given	  the	  limitations	  
in	   the	   quantity	   of	   available	   material,	   and	   possible	   tartrate	  
contamination	   in	   the	   materials	   obtained;	   the	   rotations	   were	  
unsurprisingly	  inconsistent	  in	  their	  magnitude.	  Significantly,	  all	  
the	  materials	   obtained	   following	   extraction	   for	  D-­‐DTT	   and	  D-­‐
DBT	  salts	  were	  observed	   to	  give	  positive	   rotations,	  whilst	   the	  
sample	  isolated	  following	  co-­‐precipitation	  with	  L-­‐DBT	  resulted	  
in	   samples	  with	   a	   negative	   rotation.	   CD	   spectroscopy	   proved	  
to	   be	   more	   reliable	   however;	   for	   the	   samples	   isolated	   from	  
either	  D-­‐DTT	  or	  D-­‐DBT,	  a	  positive	  Cotton	  effect	  was	  observed	  
at	  approximately	  240	  nm,	  and	  an	  equal	  and	  opposite	  effect	  for	  
the	  samples	  realised	  by	  co-­‐crystallisation	  with	  L-­‐DBT	  (Figure	  6	  
and	  S16).	  
	   The	   relative	   stability	   of	   the	   isolated	   materials	   were	  
investigated,	  with	  a	   sample	  of	  R-­‐2	   being	   left	  overnight	   in	   the	  
spectrometer	   to	   racemize,	   (20	   hours	   at	   20	   °C)	   resulting	   in	   a	  
half	   life	   of	   approximately	   13.6	   hours	   assuming	   first	   order	  
racemization	   kinetics	   (k	   =	   1.4	   x	   10-­‐5	   s-­‐1),	  whilst	   repeating	   the	  
experiment	  at	  40	  °C	  resulted	  in	  the	  half	   life	  decreasing	  to	  just	  
4.6	   hrs,	  with	   the	   other	   compounds	   showing	   similar	   half	   lives	  
determined	   at	   40	   °C	   (3.5	   and	   6.4	   hrs	   for	   R-­‐1	   and	  R-­‐3).	   There	  
was	   however	   no	   observed	   degradation	   of	   the	   crystalline	  
tartaric	  salt	  co-­‐crystals	  over	  the	  period	  of	  6	  months.	  
Conclusions	  
The	   tertiary	   cathinones	   1,	   2	   and	   3	   have	   been	   prepared	   in	  
reasonable	   yield	   and	   characterized	   using	   NMR	   and	   mass	  
spectroscopy.	   Chiral	   stationary	  phase	  HPLC	   indicates	   that	   the	  
two	   enantiomers	   can	   be	   observed,	   but	   despite	   our	   best	  
efforts,	   clear	   baseline	   separation	   could	   not	   be	   achieved.	   The	  
co-­‐crystallized	   aromatic	   tartaric	   acid	   salts	   appear	   to	   result	   in	  
single	   enantiomeric	   form,	   with	   basic	   sodium	   hydroxide	  
solutions	   encouraging	   a	   dynamic	   resolution	   probably	   via	   a	  
keto-­‐enol	   tautomerism,	   with	   the	   identity	   of	   the	   enantiopure	  
cathinone	  confirmed	  by	  X-­‐ray	  crystallography.	  Significantly,	  the	  
free	   non-­‐racemic	   amines	   could	   be	   obtained	   following	  
basification	  and	  extraction	  and	  in	  methanol	  these	  appear	  to	  be	  
reasonably	   stable	   at	   room	   temperature	   permitting	   their	  
identity	  to	  be	  determined	  by	  HPLC	  and	  CD	  spectroscopy.	  	  
	   Given	  the	  increasing	  interest	  in	  these	  materials	  due	  to	  both	  
their	  legal	  status,	  and	  their	  biological	  activity,	  these	  results	  are	  
of	  interest	  in	  a	  number	  of	  important	  areas	  of	  current	  research.	  
For	  example,	  these	  materials	  are	  being	  used	  as	  “recreational”	  
drugs,	  yet	  the	  potency	  of	  the	  two	  enantiomeric	  forms	  remains	  
unknown.	   This	   study	  demonstrates	   that	   these	   two	   forms	   can	  
now	   be	   readily	   isolated	   by	   a	   dynamic	   resolution,	   and	   in	   the	  
crystalline	   form	   they	   are	   sufficiently	   stable	   to	   be	   stored	   for	  
long	   periods	   of	   time.	   The	   free	   amines	   themselves,	   whilst	  
subject	   to	   slow	   racemization	   in	   methanol,	   are	   reasonably	  
persistent,	   and	   potentially	   show	   similar	   behavior	   at	  
physiological	  pH.	  This	   is	  within	  a	   timescale	   that	  would	  permit	  
their	  differential	  effects	  to	  be	  evaluated	  in	  biological	  media.	  	  
Experimental	  
All	   reagents	   were	   obtained	   from	   Sigma-­‐Aldrich	   and	   used	   as	  
obtained	   unless	   otherwise	   stated.	   1H	   NMR	   and	   13C	   NMR	  
spectra	   were	   recorded	   on	   either	   a	   Bruker	   AVX	   (300MHz)	   or	  
Bruker	   AVX	   (400MHz).	   Chemical	   shifts	   (δ	   ppm)	   are	   reported	  
relative	  to	  CDCl3	  (δ	  =	  7.26	  ppm)	  or	  DMSO	  (δ	  =	  2.50	  ppm).	  HPLC	  
spectra	  were	  recorded	  on	  Agilent	  1100	  Series. CHIRALCEL®	  OJ-­‐
H	  chiral	  column	  from	  Daicel	  Chemical	  Industries	  was	  used	  and	  
the	  eluent	  employed	  was	  1	  to	  3%	  2-­‐propanol	   (HPLC	  grade)	   in	  
n-­‐hexane	   (HPLC	   grade).	   CD	   spectra	   were	   recorded	   on	   J-­‐815	  
spectrometer	  under	  N2	  at	  20	  C	  and	  all	  the	  samples	  for	  CD	  test	  
were	  dissolved	  in	  methanol.	  Optical	  rotation	  was	  recorded	  on	  
Perkin	  Elmer	  341	  polarimeter.	  
	   The	   compounds	   (±)-­‐N,N-­‐dimethylcathinone	   (1)	   (±)-­‐N,N-­‐
dimethylcathinone	   (2)	   and	   (±)-­‐2-­‐(1-­‐pyrrolidinyl)-­‐
propiophenone	   (3)	   are	   subject	   to	   legislation	   under	   the	   UK	  
Misuse	  of	  Drugs	  Act	   1971.	   The	  materials	   reported	  here	  were	  
prepared	   and	   used	   under	   a	   Schedule	   1:	   Licence	   to	   produce,	  
possess	  and	  supply	  (Ref	  DH001/11)	  issued	  by	  the	  Department	  
of	  Health,	  Social	  Services	  and	  Public	  Safety	   (Northern	   Ireland)	  
to	  SJEB	  and	  NCF.	  
Synthetic	  procedures	  
(±)-­‐2-­‐Bromopropiophenone24,31	   Propiophenone	   (3.0	  mL,	   22.4	  
mmol)	   was	   dissolved	   in	   glacial	   acetic	   acid	   (63	   mL).	   Bromine	  
(1.15	  mL,	   22.4	  mmol)	  was	   added	  dropwise	   into	   the	   flask	   and	  
the	   reaction	   was	   stirred	   at	   room	   temperature	   for	   22	   hrs.	  
Aqueous	   Na2SO3	   (0.1M,	   50	   mL)	   was	   added	   and	   the	   mixture	  
extracted	  with	  dichloromethane	  (3	  x	  35	  mL).	  The	  organic	  layer	  
was	   washed	   with	   a	   saturated	   aqueous	   Na2CO3	   solution	   (100	  
mL)	   and	   dried	   with	   MgSO4	   and	   concentrated	   under	   vacuum	  
giving	   the	   product	   as	   a	   yellow	   oil,	   which	   was	   used	   without	  
further	  purification.	  Yield	  =	  90%.	  1H	  NMR	  (CDCl3,	  300	  MHz):	  δH	  
=	  8.02	  (2H,	  d,	  J	  =	  7.4	  Hz,	  ArH),	  7.58	  (1H,	  t,	  ArH),	  7.47	  (2H,	  t,	  J	  =	  
7.4	  Hz,	  ArH),	  5.30	  (1H,	  q,	  J	  =	  7.0	  Hz,	  CHBrCH3),	  1.90	  (3H,	  d,	  J	  =	  
7.0	  Hz,	  CHCH3);	  
13C	  NMR	  (CDCl3,	  100	  MHz):	  δC	  =	  193.4,	  134.0,	  
133.7,	  128.9,	  41.4,	  20.1;	  m/z	   TOF	  MS	  EI+:	  211.9861	   ([M79Br]+,	  
theoretical	   =	   211.9837),	   132.0760	   ([C9H8O]





(±)-­‐N,N-­‐dimethylcathinone	   (1)37,54	   Dimethylamine	   hydro-­‐
chloride	  (297	  mg,	  3.65	  mmol)	  and	  triethylamine	  (0.98	  mL,	  7.00	  
mmol)	  dissolved	  in	  dichloromethane	  (38	  mL)	  were	  added	  to	  2-­‐
bromopropiophenone	   (773	   mg,	   3.63	   mmol)	   in	  
dichloromethane	   (23.5	  mL)	   and	   stirred	   at	   room	   temperature	  
for	  21	  hrs.	  The	  aqueous	   layer	  was	  acidified	  with	  aqueous	  HCl	  
solution	   (0.1	   M,	   100	   mL)	   and	   washed	   with	   dichloromethane	  
(100	  mL).	   The	   pH	  was	   then	   adjusted	   to	   10	   using	   an	   aqueous	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NaOH	   solution	   (0.5	   M,	   20	   mL)	   and	   extracted	   into	  
dichloromethane	   (2	   ×	   100	   mL),	   dried	   with	   MgSO4	   and	  
concentrated	  under	  vacuum	  giving	  the	  product	  as	  a	  yellow	  oil.	  
Yield	  =	  511	  mg,	  80%	  yield.	  1H	  NMR	  (CDCl3,	  300	  MHz):	  δH	  =	  8.07	  
(2H,	  d,	  J	  =	  7.5	  Hz,	  ArH),	  7.56	  (1H,	  d,	  J	  =	  7.5	  Hz,	  ArH),	  7.46	  (2H,	  t,	  
J	   =	   7.5	  Hz,	   ArH),	   4.07	   (1H,	   q,	   J	   =	   6.8	  Hz,	  CHCH3),	   2.32	   (6H,	   s,	  
N(CH3)2),	  1.27	  (3H,	  d,	  J	  =	  6.8	  Hz,	  CHCH3);	  
13C	  NMR	  (CDCl3,	  100	  
MHz):	  δC	  =	  199.8,	  135.2,	  131.6,	  127.6,	  63.3,	  40.3,	  9.8;	  m/z	  TOF	  
MS	   EI+:	   177.1222	   ([M]+,	   theoretical	   =	   177.1154),	   133.0605	  
([C9H9O]
+),	   105.0304	   ([C7H5O]
+),	   77.0343	   ([C6H5]
+);	   HPLC	  
retention	  time:	  7.47	  min	  and	  7.88	  min	  (OJ-­‐H	  chiral	  column,	  3%	  
2-­‐propanol	  in	  n-­‐hexane,	  298	  K).	  
	  
(±)-­‐N,N-­‐diethylcathinone	   (2)	   was	   prepared	   according	   to	   the	  
same	   procedure	   to	   2-­‐(N,N-­‐dimethylamino)-­‐propiophenone	  
using	   diethylamine	   hydrochloride	   (372	   mg,	   3.10	   mmol),	  
triethylamine	   (0.95	   mL,	   6.86	   mmol)	   and	   2-­‐
bromopropiophenone	   (811	   mg,	   2.99	   mmol)	   as	   a	   yellow	   oil.	  
Yield	  =	  395	  mg,	  62%.	  1H	  NMR	  (CDCl3,	  300	  MHz):	  δH	  =	  8.10	  (2H,	  
d,	  J	  =	  7.5	  Hz,	  ArH),	  7.53	  (1H,	  t,	  J	  =	  7.5	  Hz,	  ArH),	  7.43	  (2H,	  t,	  J	  =	  
7.5	  Hz,	  ArH),	  4.37	  (1H,	  q,	  J	  =	  6.7	  Hz,	  CHCH3),	  2.59-­‐2.47	  (4H,	  m,	  
N(CH2CH3)2),	  1.23	  (3H,	  d,	  J	  =	  6.7	  Hz,	  CHCH3),	  1.01	  (6H,	  t,	  J	  =	  7.1	  
Hz,	   N(CH2CH3)2);	  
13C	   NMR	   (CDCl3,	   100	   MHz):	   	   δC	   =	   202.20,	  
136.83,	   132.52,	   129.00,	   60.44,	   44.14,	   13.61,	   10.10;	  m/z	   TOF	  
MS	   EI+:	   205.1454	   ([M]+,	   theoretical	   =	   205.1467),	   133.0589	  
([C9H9O]
+),	   100.1049	   ([C6H14N]
+),	   77.0332	   ([C6H5]
+);	   HPLC	  
retention	  time:	  7.43	  min,	  7.74	  min	  (OJ-­‐H	  chiral	  column,	  3%	  2-­‐
propanol	  in	  n-­‐hexane,	  298	  K).	  
	  
(±)-­‐2-­‐(1-­‐pyrrolidinyl)-­‐propiophenone	   (3)	   was	   prepared	  
according	   to	   the	   same	   procedure	   to	   2-­‐(N,N-­‐dimethylamino)-­‐
propiophenone	  using	  pyrrolidine	  (0.30	  mL,	  3.65	  mmol)	  and	  2-­‐
bromopropiophenone	   (942	   mg,	   4.44	   mmol)	   as	   a	   brown	   oil.	  
Yield	  =	  481	  mg,	  65%.	  1H	  NMR	  (CDCl3,	  300	  MHz):	  δH	  =	  8.11	  (2H,	  
d,	  J	  =	  7.5	  Hz,	  ArH),	  7.56	  (1H,	  t,	  J	  =	  7.5	  Hz,	  ArH),	  7.46	  (2H,	  t,	  J	  =	  
7.5	  Hz,	  ArH),	  3.98	  (1H,	  q,	  J	  =	  6.9	  Hz,	  CHCH3),	  2.66-­‐2.59	  (4H,	  m,	  
NCH2CH2),	  1.83-­‐1.77	  (4H,	  m,	  CH2CH2-­‐),	  1.39	  (3H,	  d,	  J	  =	  6.9	  Hz,	  
CHCH3);	  
13C	   NMR	   (CDCl3,	   100	   MHz):	   	   δC	   =	   202.20,	   136.83,	  
132.52,	   129.00,	   60.44,	   44.14,	   13.61,	   10.10;	  m/z	   TOF	   MS	   EI+:	  
203.1328	   ([M]+,	   theoretical	   203.1310),	   98.0943	   ([C6H12N]
+)	  
77.0354	   ([C6H5]
+),	   68.0471,	   ([C4H8N]
+);	   HPLC	   retention	   time:	  
11.45	  min,	  11.89	  min	  (OJ-­‐H	  chiral	  column,	  3%	  2-­‐propanol	  in	  n-­‐
hexane,	  298	  K).	  
	  
(+)-­‐O,Oʹ′-­‐di-­‐p-­‐toluoyl-­‐D-­‐tartaric,	   (+)-­‐O,Oʹ′-­‐dibenzoyl-­‐D-­‐tartaric	  
(D-­‐DTT),	   (+)-­‐O,Oʹ′-­‐dibenzoyl-­‐L-­‐tartaric	   (L-­‐DBT)	   and	   (-­‐)-­‐O,Oʹ′-­‐
dibenzoyl-­‐L-­‐tartaric	   (L-­‐DBT)	   acid	   salts	   of	   N,N-­‐
dimethylcathinone	   (1),	  N,N-­‐dimethylcathinone	   (2)	   and	   2-­‐(1-­‐
pyrrolidinyl)-­‐propiophenone	   (3)	   In	   a	   typical	   procedure,	  
compound	   1,	   2	   or	   3	   (in	   the	   range	   of	   0.5	  mmol	   to	   4.0	  mmol	  
depending	   on	   availability)	   was	   dissolved	   in	   acetone	   (approx.	  
0.1M),	  the	  appropriate	  tartaric	  acid	  (one	  equivalent	  relative	  to	  
the	   cathinone)	   in	   water	   (approx.	   0.1	   M)	   and	   aqueous	   NaOH	  
solution	  (0.1	  M,	  one	  equivalent	  relative	  to	  the	  cathinone)	  were	  
left	   to	   crystallize	   at	   room	   temperature	   in	   a	   loosely	   covered	  
beaker	  over	  the	  period	  of	  several	  days.	  The	  resulting	  crystals	  /	  
precipitates	   were	   collected	   by	   filtration,	   washed	   with	   a	   little	  
distilled	  water	  and	  dried	  at	  room	  temperature.	  	  
	  
S-­‐N,N-­‐Dimethylcathinone	   D-­‐DTT	   salt	   (1-­‐D-­‐DT)	   large	   white	  
crystals,	  yield	  =	  68%.	  1H	  NMR	  (DMSO-­‐D6,	  400	  MHz):	  δH	  =	  8.02	  
(2H,	  d,	  J	  =	  8.0	  Hz,	  ArH),	  7.85	  (4H,	  d,	  J	  =	  8.1	  Hz,	  Tol),	  7.68	  (1H,	  t,	  
J	  =	  7.3	  Hz,	  ArH),	  7.56	  (2H,	  dd,	  J	  =	  7.3,	  8.0	  Hz,	  ArH),	  7.35	  (4H,	  d,	  J	  
=	   8.1	   Hz,	   Tol),	   4.69	   (1H,	   q,	   J	   =	   6.7	   Hz,	   CHCH3),	   2.45	   (6H,	   s,	  
TolCH3),	  2.38	   (6H,	  s,	  N(CH3)2),	  1.25	   (3H,	  d,	   J	  =	  6.7	  Hz,	  CHCH3);	  
m/z	   TOF	  MS	  EI+:	   741.3358	   ([MH+1]+,	   theoretical	   =	   741.3387),	  
564.2187	   ([MH]+,	   theoretical	   =	   564.2234),	   178.1153	   ([MH-­‐
DTT]+,	  theoretical	  =	  178.1232).	  
	  
S-­‐N,N-­‐Dimethylcathinone	  D-­‐DBT	  salt	  (1-­‐D-­‐DBT)	  white	  crystals,	  
yield	  =	  60%.	  1H	  NMR	  (DMSO-­‐D6,	  400	  MHz):	  δH	  =	  8.02	  (2H,	  d,	  J	  =	  
7.5	  Hz,	  ArH),	  7.98	   (4H,	  d,	   J	   =	  7.5	  Hz,	  Benz),	  7.71-­‐7.66	   (3H,	  m,	  
ArH),	  7.58-­‐7.52	  (6H,	  m,	  Benz),	  4.71	  (1H,	  br,	  CHCH3),	  2.47	  (6H,	  s,	  
N(CH3)2),	   1.26	   (3H,	  m,	   CHCH3);	   );	  m/z	   TOF	  MS	   EI
+:	   	   536.2458	  
([MH]+,	   theoretical	   536.1921),	   178.1098	   ([MH-­‐DBT]+,	  
theoretical	  =	  178.1232).	  
	  
R-­‐N,N-­‐Dimethylcathinone	   L-­‐DBT	  salt	   (1-­‐L-­‐DBT)	  white	  crystals,	  
Yield	  =	  54%.	  1H	  NMR	  (DMSO-­‐D6,	  400	  MHz):	  δH	  =	  8.02	  (2H,	  d,	  J	  =	  
7.5	  Hz,	  ArH),	  7.98	   (4H,	  d,	   J	   =	  7.5	  Hz,	  Benz),	  7.71-­‐7.66	   (3H,	  m,	  
ArH),	  7.58-­‐7.52	  (6H,	  m,	  Benz),	  4.70	  (1H,	  br,	  CHCH3),	  2.45	  (6H,	  s,	  
N(CH3)2),	   1.26	   (3H,	   t,	   J	   =	   6.7	   Hz,	   CHCH3);	   m/z	   TOF	   MS	   EI
+:	  	  
536.3618	   ([MH]+,	   theoretical	   =	   536.1921),	   178.1176	   ([MH-­‐
DBT]+,	  theoretical	  =	  178.1232).	  
	  
S-­‐N,N-­‐Diethylcathinone	   D-­‐DTT	   salt	   (2-­‐D-­‐DTT)	   yellow	  
precipitate,	   yield	   =	   78%.	   1H	   NMR	   (DMSO-­‐D6,	   400	  MHz):	   δH	   =	  
8.05	  (2H,	  d,	  J	  =	  7.8	  Hz,	  ArH),	  7.85	  (4H,	  d,	  J	  =	  8.1	  Hz,	  Tol),	  7.66	  
(1H,	  t,	  J	  =	  7.5	  Hz,	  ArH),	  7.54	  (2H,	  dd,	  J	  =	  7.8,	  7.5	  Hz,	  ArH),	  7.35	  
(4H,	  d,	   J	  =	  8.1	  Hz,	  ArH),	  4.75	   (1H,	  q,	   J	  =	  6.9	  Hz,	  CHCH3),	  2.88-­‐
2.68	  (4H,	  m,	  N(CH2CH3)2),	  2.37	  (6H,	  s,	  TolCH3),	  1.24	  (3H,	  d,	  J	  =	  
6.9	  Hz,	   CHCH3),	   1.06	   (6H,	   t,	   J	   =	   6.9	  Hz,	  N(CH2CH3)2);	  m/z	   TOF	  
MS	  EI+:	  	  796.2039	  ([MH+2]+,	  theoretical	  =	  796.3935),	  206.1425	  
([MH-­‐DTT]+,	  theoretical	  =	  206.1545).	  
	  
S-­‐N,N-­‐Diethylcathinone	   D-­‐DBT	   salt	   (2-­‐D-­‐DBT),	   yellow	  
precipitate,	   yield	   =	   85%.	   1H	   NMR	   (DMSO-­‐D6,	   400	  MHz):	   δH	   =	  
8.05	  (2H,	  d,	  J	  =	  7.6	  Hz,	  ArH),	  7.98	  (4H,	  d,	  J	  =	  7.7	  Hz,	  Benz),	  7.72-­‐
7.64	   (3H,	   m,	   ArH),	   7.58-­‐7.52	   (6H,	   m,	   Benz),	   4.85	   (1H,	   br,	  
CHCH3),	  2.83-­‐2.72	  (4H,	  br,	  N(CH2CH3)2),	  1.24	  (3H,	  d,	  J	  =	  6.4	  Hz,	  
CHCH3),	   1.05	   (6H,	   t,	   J	   =	  6.9	  Hz,	  N(CH2CH3)2);	  m/z	   TOF	  MS	  EI
+:	  	  
769.4525	   ([MH+2]+,	   theoretical	   =	   769.3700),	   564.2867	   ([M]+,	  
theoretical	   564.2233),	   206.1601	   206.1425	   ([MH-­‐DBT]+,	  
theoretical	  =	  206.1545).	  
	  
R-­‐N,N-­‐Diethylcathinone	   L-­‐DBT	   salt	   (2-­‐L-­‐DBT)	   off	   white	  
precipitate,	   yield	   =	   24%.	   1H	   NMR	   (DMSO-­‐D6,	   400	  MHz):	   δH	   =	  
8.06	  (2H,	  d,	  J	  =	  7.5	  Hz,	  ArH),	  7.98	  (4H,	  d,	  J	  =	  7.6	  Hz,	  Benz),	  7.72-­‐
7.64	   (3H,	   m,	   ArH),	   7.58-­‐7.52	   (6H,	   m,	   Benz),	   4.83(1H,	   br,	  
CHCH3),	  2.83-­‐2.72	  (4H,	  br,	  N(CH2CH3)2),	  1.25	  (3H,	  d,	  J	  =	  6.3	  Hz,	  
CHCH3),	  1.06	   (6H,	  d,	   J	  =	  6.8	  Hz,	  N(CH2CH3)2);	  m/z	  TOF	  MS	  EI
+:	  
769.3741	   ([MH+2]+,	   theoretical	   =	   769.3700),	   564.2441	   ([M]+,	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theoretical	   564.2233),	   206.1317	   206.1425	   ([MH-­‐DBT]+,	  
theoretical	  =	  206.1545).	  
	  
S-­‐2-­‐(1-­‐Pyrrolidinyl)-­‐propiophenone	   D-­‐DTT	   salt	   (3-­‐D-­‐DTT),	  
white	  precipitate,	  yield	  =	  22%.	   1H	  NMR	  (DMSO-­‐D6,	  400	  MHz):	  
δH	  =	  8.03	  (2H,	  d,	  J	  =	  7.9	  Hz,	  ArH),	  7.84	  (4H,	  d,	  J	  =	  8.1	  Hz,	  Tol),	  
7.72	  (1H,	  t,	  J	  =	  7.5	  Hz,	  ArH),	  7.59	  (2H,	  dd,	  J	  =	  7.5,	  7.9	  Hz,	  ArH),	  
7.32	  (4H,	  t,	  J	  =	  8.1	  Hz,	  Tol),	  4.98	  (1H,	  q,	  J	  =	  6.3	  Hz,	  CHCH3),	  3.11-­‐
3.02	  (4H,	  m,	  NCH2CH2),	  2.37	  (6H,	  s,	  TolMe),	  1.89-­‐1.80	  (4H,	  m,	  
CH2CH2),	   1.39	   (3H,	   d,	   J	   =	   6.3Hz,	   CHCH3);	   m/z	   TOF	   MS	   EI
+:	  	  
793.3068	   ([MH+3]+,	   theoretical	   =	   793.3700),	   590.1918	   ([M]+,	  
theoretical	   =	   590.2390),	   204.1028	   ([MH-­‐DTT]+,	   theoretical	   =	  
204.1388).	  
	  
S-­‐2-­‐(1-­‐Pyrrolidinyl)-­‐propiophenone	  D-­‐DBT	  salt	  (3-­‐D-­‐DBT),	  pale	  
orange	  precipitate,	  yield	  =	  53%.	  1H	  NMR	  (DMSO-­‐D6,	  400	  MHz):	  
δH	  =	  8.02	  (2H,	  d,	  J	  =	  7.5	  Hz,	  ArH),	  7.96	  (4H,	  d,	  J	  =	  7.8	  Hz,	  Benz),	  
7.72	  (1H,	  t,	  J	  =	  7.5	  Hz,	  ArH),	  7.66	  (2H,	  t,	  J	  =	  7.5	  Hz,	  ArH),	  7.59	  
(2H,	  t,	  J	  =	  7.8	  Hz,	  Benz),	  7.52	  (4H,	  t,	  J	  =	  7.8	  Hz,	  Benz),	  5.00	  (1H,	  
br,	   CHCH3),	   3.12-­‐3.03	   (4H,	   br,	   NCH2CH2),	   1.85-­‐1.77	   (4H,	   m,	  
CH2CH2),	   1.37	   (3H,	   d,	   J	   =	   6.7	   Hz,	   CHCH3);	   m/z	   TOF	   MS	   EI
+:	  	  
765.3441	   ([MH+3]+,	   theoretical	   =	   765.3387),	   562.2391	   ([M]+,	  
theoretical	   562.2077),	   204.1170	   ([MH-­‐DBT]+,	   theoretical	   =	  
204.1388).	  
	  
R-­‐2-­‐(1-­‐Pyrrolidinyl)-­‐propiophenone	   L-­‐DBT	   salt	   (3-­‐L-­‐DBT)	  
orange	  precipitate,	  yield	  =	  61%.	  1H	  NMR	  (DMSO-­‐D6,	  400	  MHz):	  
δH	  =	  8.04	  (2H,	  d,	  J	  =	  7.5	  Hz,	  ArH),	  7.95	  (4H,	  d,	  J	  =	  7.8	  Hz,	  Benz),	  
7.73	  (1H,	  t,	  J	  =	  7.5	  Hz,	  ArH),	  7.65	  (2H,	  t,	  J	  =	  7.5	  Hz,	  ArH),	  7.59	  
(2H,	  t,	  J	  =	  7.8	  Hz,	  Benz),	  7.52	  (4H,	  t,	  J	  =	  7.8	  Hz,	  Benz),	  5.00	  (1H,	  
br,	   CHCH3),	   3.12-­‐3.03	   (4H,	   br,	   NCH2CH2),	   1.85-­‐1.77	   (4H,	   m,	  
CH2CH2),	   1.37	   (3H,	   d,	   J	   =	   6.7	   Hz,	   CHCH3);	   m/z	   TOF	   MS	   EI
+:	  	  
765.3456	   ([MH+3]+,	   theoretical	   =	   765.3387),	   562.2148	   ([M]+,	  
theoretical	   =	   562.2077),	   204.1349	   ([MH-­‐DBT]+,	   theoretical	   =	  
204.1388).	  
	  
Conversion	  of	   the	   tartaric	   acid	   salts	   to	   the	  non-­‐racemic-­‐free	  
amines.	   In	   a	   typical	   procedure,	   the	   tartrate	   salts	   (20	   mg,	  
approx.	   0.10	   mmol)	   were	   dissolved	   in	   aqueous	   sodium	  
hydroxide	   solution	   (0.1M,	   15mL).	   The	  mixture	   was	   extracted	  
by	  dichloromethane	   (20	  mL)	  and	   the	  organic	   layer	  dried	  with	  
MgSO4	  and	  concentrated	  under	  vacuum	  to	  give	  a	  yellow	  oil	  in	  
was	   obtained	   in	   a	   range	   of	   56	   to	   83%	   yield	   (0.005g).	   1H,	   13C	  
NMR	   and	   OF	   MS	   EI+	   characterization	   of	   samples	   was	   in	  
accordance	  with	  that	  of	  the	  racemic	  mixtures	  of	  1,	  2	  and	  3.	  
	  
S-­‐2-­‐(Dimethylamino)-­‐propiophenone	   (S-­‐1)	   CD	   λmax	   ([Δε])	  
(methanol,	   293K):	   235	   nm	   (+	   3.43	   x	   103	   M-­‐1cm-­‐1);	   	   =	  
+10.8	  °	  (c=	  1.01	  mg	  mL-­‐1,	  methanol).	  
	  
R-­‐2-­‐(Dimethylamino)-­‐propiophenone	   (R-­‐1)	   CD	   λmax	   ([Δε])	  
(methanol,	  293K):	  235	  nm	  (-­‐	  3.16	  x	  103	  M-­‐1cm-­‐1);	   	  =	  -­‐8.7	  
°	  (c=	  2.31	  mg	  mL-­‐1,	  methanol).	  
	  
S-­‐2-­‐(Diethylamino)-­‐propiophenone	   (S-­‐2)	   CD	   λmax	   ([Δε])	  
(methanol,	   293K):	   240nm	   (+	   1.80	   x	   103	   M-­‐1cm-­‐1);	   	   =	  
+9.854°	  (c=	  1.76	  mg	  mL-­‐1,	  methanol)	  	  
	  
R-­‐2-­‐(Diethylamino)-­‐propiophenone	   (R-­‐2)	   CD	   λmax	   ([Δε])	  
(methanol,	   293K):	   240	   nm	   (-­‐	   1.83	   x	   103	  M-­‐1cm-­‐1);	   	   =	   -­‐
15.444°	  (c=	  2.59	  mg	  mL-­‐1,	  methanol)	  	  
	  
S-­‐2-­‐(1-­‐Pyrrolidinyl)-­‐propiophenone	   (S-­‐3)	   CD	   λmax	   ([Δε])	  
(methanol,	   293K):	   240	   nm	   (+	   0.61	   x	   103	   M-­‐1cm-­‐1);	   	   =	  
+8.139°	  (c=	  2.33	  g	  mL-­‐1,	  methanol)	  
	  
R-­‐2-­‐(1-­‐Pyrrolidinyl)-­‐propiophenone	   (R-­‐3);	   CD	   λmax	   (Δε)	  
(methanol,	   293K):	   240	   nm	   (-­‐	   0.61	   x	   103	  M-­‐1cm-­‐1);	   	   =	   -­‐
6.301°	  (c=	  1.75	  g	  mL-­‐1,	  methanol).	  
Crystallography	  
S-­‐2-­‐(Dimethylamino)-­‐propiophenone	   D-­‐DTT	   salt	   (1-­‐D-­‐DTT)	  
Data	  were	  collected	  on	  a	  Rigaku	  AFC12	  goniometer	  equipped	  
with	   an	   enhanced	   sensitivity	   (HG)	   Saturn724+	   detector	  
mounted	  at	  the	  window	  of	  an	  FR-­‐E+	  SuperBright	  molybdenum	  
rotating	   anode	   generator	   with	   VHF	   Varimax	   optics	   (70µm	  
focus).	  Cell	  determination,	  data	  collection,	  data	  reduction,	  cell	  
refinement	   and	   absorption	   correction	   were	   completed	   using	  
CrystalClear-­‐SM	   Expert	   3.1	   b27.58	   Structure	   solution	   was	  
performed	   using	   SUPERFLIP59	   and	   the	   Structure	   refinement	  
using	   SHELXL-­‐2015.60	   Graphics	   were	   prepared	   using	   ORTEP3	  
for	   Windows61	   and	   Mercury	   3.5.1.62	   Additional	   material	  
available	   from	   the	   Cambridge	   Crystallographic	   Data	   Centre	  
comprises	  relevant	  tables	  of	  atomic	  coordinates,	  bond	  lengths	  
and	  angles,	  and	  thermal	  parameters	  (CCDC	  Number	  1407691).	  
It	   was	   not	   possible	   to	   accurately	   determine	   the	   absolute	  
configuration;	  the	  enantiomer	  has	  been	  assigned	  by	  reference	  
to	  the	  absolute	  configuration	  of	  (+)-­‐O,Oʹ′-­‐di-­‐p-­‐toluoyl-­‐D-­‐tartaric	  
acid.	  C31H33F12NO9:-­‐	  M	  =	  563.58,	  Monoclinic,	  space	  group	  P21,	  
a	   =	   8.2681(5)	   Å,	   b	   =	   7.5543(5)	   Å,	   c	   =	   23.4201(17)	   Å,	   β	   =	  
96.148(3)°,	  Vol.	  =	  1454.40(17)	  Å3,	  Z	  =	  2,	  Absorb.	  coef.	  =	  0.095	  
mm−1,	  a	  total	  of	  13021	  reflections	  were	  measured	  for	  the	  angle	  
range	   2.478	   −	   27.514°,	   6380	   [Rint	   =	   0.0994]	   independent	  
reflections	  were	  used	  in	  the	  refinement.	  The	  final	  R	  indices	  	  [F2	  
>	  2σ(F2)]]	  were	  R1	  =	  0.0865,	  wR2	  =	  0.1920,	  and	  a	  GOF	  on	  F2	  at	  
1.037.	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